Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears SurgiQuest's "breakthrough" laparoscopy kit

This article was originally published in Clinica

Executive Summary

The US FDA has granted 510(k) clearance for SurgiQuest's 5mm AnchorPort trocars for use during single incision laparoscopic surgery. Trocars are round pens with a pointed end that are used to introduce ports for minimally-invasive surgery. The Orange, Connecticut company claims it is the world's first and only trocar with an elastic, stretchable cannula system – this adjusts to the patient's abdominal wall thickness, its distal tip anchoring the device in place within the abdominal wall and giving surgeons more freedom of movement. Conventional fixed-length trocars are rigid and protrude into the abdominal cavity, which can interfere with other surgical instruments, limiting manoeuvrability, SurgiQuest says. The AnchorPort device also has a softer outer skin so causes less trauma to tissue, the firm added.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT094767

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel